TELA Bio, Inc. (TELA) › Operating IncomeTELA Bio, Inc. (TELA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2017: -$16.92M2018: -$17.78M2019: -$19.16M2020: -$25.27M2021: -$29.45M2022: -$39.01M2023: -$44.08M2024: -$34.12M2025: -$33.76M-$33.76M2017Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$33.76M+1.1%2024-$34.12M+22.6%2023-$44.08M-13.0%2022-$39.01M-32.4%2021-$29.45M-16.5%2020-$25.27M-31.9%2019-$19.16M-7.8%2018-$17.78M-5.1%2017-$16.92M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share